BARCLAYS PLC - SUTRO BIOPHARMA INC ownership

SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 81 filers reported holding SUTRO BIOPHARMA INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of SUTRO BIOPHARMA INC
ValueSharesWeighting
Q2 2024$164
-63.6%
56,262
-29.4%
0.00%
Q1 2024$450
-20.5%
79,738
-39.6%
0.00%
Q4 2023$566
+160.8%
132,059
+111.0%
0.00%
Q3 2023$217
+4.8%
62,579
+40.7%
0.00%
Q2 2023$207
-63.0%
44,486
-63.3%
0.00%
Q1 2023$559
-15.4%
121,144
+47.9%
0.00%
Q4 2022$661
-99.4%
81,899
+300.9%
0.00%
Q3 2022$114,000
-8.8%
20,429
-14.3%
0.00%
Q2 2022$125,000
-71.7%
23,838
-55.5%
0.00%
Q1 2022$441,000
-95.8%
53,591
-92.4%
0.00%
-100.0%
Q4 2021$10,546,000
+68.8%
708,774
+114.4%
0.00%
-33.3%
Q3 2021$6,247,000
+40.6%
330,624
+38.3%
0.00%
+50.0%
Q2 2021$4,443,000
-24.9%
238,994
-8.1%
0.00%
-33.3%
Q1 2021$5,919,000
+18.5%
260,123
+13.0%
0.00%0.0%
Q4 2020$4,995,000
+107.9%
230,119
-3.8%
0.00%
+200.0%
Q3 2020$2,403,000
+30.5%
239,125
+0.7%
0.00%0.0%
Q2 2020$1,841,000
-21.5%
237,359
+3.2%
0.00%
-50.0%
Q1 2020$2,346,000
+1061.4%
229,941
+1156.6%
0.00%
Q4 2019$202,000
+74.1%
18,299
+43.7%
0.00%
Q3 2019$116,000
+4.5%
12,732
+30.9%
0.00%
Q2 2019$111,000
+428.6%
9,726
+438.5%
0.00%
Q1 2019$21,000
+133.3%
1,806
+80.8%
0.00%
Q4 2018$9,0009990.00%
Other shareholders
SUTRO BIOPHARMA INC shareholders Q2 2020
NameSharesValueWeighting ↓
SV Health Investors, LLC 1,824,542$41,527,00015.56%
Samsara BioCapital, LLC 1,675,579$38,136,0007.03%
First Light Asset Management, LLC 2,058,447$46,850,0003.11%
FRAZIER MANAGEMENT LLC 1,001,421$22,792,0001.83%
AJU IB Investment Co., Ltd. 175,000$3,983,0001.50%
Altium Capital Management LP 226,719$5,160,0001.43%
Opaleye Management Inc. 341,950$7,783,0001.14%
Parkman Healthcare Partners LLC 202,696$4,613,0001.07%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 139,331$3,171,0000.84%
Eventide Asset Management 2,370,975$53,963,0000.80%
View complete list of SUTRO BIOPHARMA INC shareholders